Phosphorylation at serine 482 affects stability of NF90 and its functional role in mitosis

Cell Proliferation

Volumn 44, Issue 2, 2011, Pages 147-155

  Smith, N L ^a   Miskimins, W K ^a,b  

^a UNIVERSITY OF SOUTH DAKOTA   (United States)

^b SANFORD RESEARCH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN ENHANCER BINDING FACTOR 3; SERINE; SERINE 482; UNCLASSIFIED DRUG;

ARTICLE; CELL CYCLE; CELL STRAIN MCF 7; FLOW CYTOMETRY; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; IN VIVO STUDY; MITOSIS; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; PROTEIN STABILITY; PROTEOMICS; WESTERN BLOTTING;

AMINO ACID SUBSTITUTION; CELL LINE; HUMANS; MASS SPECTROMETRY; MITOSIS; MUTAGENESIS, SITE-DIRECTED; NUCLEAR FACTOR 90 PROTEINS; PHOSPHOPEPTIDES; PHOSPHORYLATION; SERINE;

EID: 79952640471     PISSN: 09607722     EISSN: 13652184     Source Type: Journal    
DOI: 10.1111/j.1365-2184.2011.00742.x     Document Type: Article

References (44)

1. Duchange N, Pidoux J, Camus E, Sauvaget D (2000) Alternative splicing in the human interleukin enhancer binding factor 3 (ILF3) gene. Gene 261, 345-353.
2. Saunders LR, Perkins DJ, Balachandran S, Michaels R, Ford R, Mayeda A et al. (2001) Characterization of two evolutionarily conserved, alternatively spliced nuclear phosphoproteins, NFAR-1 and -2, that function in mRNA processing and interact with the double-stranded RNA-dependent protein kinase, PKR. J. Biol. Chem. 276, 32300-32312.
3. Marcoulatos P, Avgerinos E, Tsantzalos DV, Vamvakopoulos NC (1998) Mapping interleukin enhancer binding factor 3 gene (ILF3) to human chromosome 19 (19q11-qter and 19p11-p13.1) by polymerase chain reaction amplification of human-rodent somatic cell hybrid DNA templates. J. Interferon Cytokine Res. 18, 351-355.
4. Xu YH, Grabowski GA (1999) Molecular cloning and characterization of a translational inhibitory protein that binds to coding sequences of human acid beta-glucosidase and other mRNAs. Mol. Genet. Metab. 68, 441-454.
5. Matsumoto-Taniura N, Pirollet F, Monroe R, Gerace L, Westendorf JM (1996) Identification of novel M phase phosphoproteins by expression cloning. Mol. Biol. Cell 7, 1455-1469.
6. Patel RC, Vestal DJ, Xu Z, Bandyopadhyay S, Guo W, Erme SM et al. (1999) DRBP76, a double-stranded RNA-binding nuclear protein, is phosphorylated by the interferon-induced protein kinase, PKR. J. Biol. Chem. 274, 20432-20437.
7. Corthesy B, Kao PN (1994) Purification by DNA affinity chromatography of two polypeptides that contact the NF-AT DNA binding site in the interleukin 2 promoter. J. Biol. Chem. 269, 20682-20690.
8. Kao PN, Chen L, Brock G, Ng J, Kenny J, Smith AJ et al. (1994) Cloning and expression of cyclosporin A- and FK506-sensitive nuclear factor of activated T-cells: NF45 and NF90. J. Biol. Chem. 269, 20691-20699.
9. Sakamoto S, Morisawa K, Ota K, Nie J, Taniguchi T (1999) A binding protein to the DNase I hypersensitive site II in HLA-DR alpha gene was identified as NF90. Biochemistry 38, 3355-3361.
10. Kiesler P, Haynes PA, Shi L, Kao PN, Wysocki VH, Vercelli D (2010) NF45 and NF90 regulate HS4-dependent interleukin-13 transcription in T cells. J. Biol. Chem. 285, 8256-8267.
11. Aoki Y, Zhao G, Qiu D, Shi L, Kao PN (1998) CsA-sensitive purine-box transcriptional regulator in bronchial epithelial cells contains NF45, NF90, and Ku. Am. J. Physiol. 275, L1164-L1172.
12. Reichman TW, Muniz LC, Mathews MB (2002) The RNA binding protein nuclear factor 90 functions as both a positive and negative regulator of gene expression in mammalian cells. Mol. Cell. Biol. 22, 343-356.
13. Agbottah ET, Traviss C, McArdle J, Karki S, St Laurent GC III, Kumar A (2007) Nuclear Factor 90(NF90) targeted to TAR RNA inhibits transcriptional activation of HIV-1. Retrovirology 4, 41.
14. Shim J, Lim H, Yates R, Karin M (2002) Nuclear export of NF90 is required for interleukin-2 mRNA stabilization. Mol. Cell 10, 1331-1344.
15. Shi L, Zhao G, Qiu D, Godfrey WR, Vogel H, Rando TA et al. (2005) NF90 regulates cell cycle exit and terminal myogenic differentiation by direct binding to the 3'-untranslated region of MyoD and p21WAF1/CIP1 mRNAs. J. Biol. Chem. 280, 18981-18989.
16. Vumbaca F, Phoenix KN, Rodriguez-Pinto D, Han DK, Claffey KP (2008) Double-stranded RNA-binding protein regulates vascular endothelial growth factor mRNA stability, translation, and breast cancer angiogenesis. Mol. Cell. Biol. 28, 772-783.
17. Kuwano Y, Kim HH, Abdelmohsen K, Pullmann R Jr, Martindale JL, Yang X et al. (2008) MKP-1 mRNA stabilization and translational control by RNA-binding proteins HuR and NF90. Mol. Cell. Biol. 28, 4562-4575.
18. Pullmann R Jr, Kim HH, Abdelmohsen K, Lal A, Martindale JL, Yang X et al. (2007) Analysis of turnover and translation regulatory RNA-binding protein expression through binding to cognate mRNAs. Mol. Cell. Biol. 27, 6265-6278.
19. Kuwano Y, Pullmann R Jr, Marasa BS, Abdelmohsen K, Lee EK, Yang X et al. (2010) NF90 selectively represses the translation of target mRNAs bearing an AU-rich signature motif. Nucleic Acids Res. 38, 225-238.
20. Parrott AM, Mathews MB (2007) Novel rapidly evolving hominid RNAs bind nuclear factor 90 and display tissue-restricted distribution. Nucleic Acids Res. 35, 6249-6258.
21. Sakamoto S, Aoki K, Higuchi T, Todaka H, Morisawa K, Tamaki N et al. (2009) The NF90-NF45 complex functions as a negative regulator in the microRNA processing pathway. Mol. Cell. Biol. 29, 3754-3769.
22. Parrott AM, Walsh MR, Reichman TW, Mathews MB (2005) RNA binding and phosphorylation determine the intracellular distribution of nuclear factors 90 and 110. J. Mol. Biol. 348, 281-293.
23. Guan D, Altan-Bonnet N, Parrott AM, Arrigo CJ, Li Q, Khaleduzzaman M et al. (2008) Nuclear factor 45 (NF45) is a regulatory subunit of complexes with NF90/110 involved in mitotic control. Mol. Cell. Biol. 28, 4629-4641.
24. Ting NS, Kao PN, Chan DW, Lintott LG, Lees-Miller SP (1998) DNA-dependent protein kinase interacts with antigen receptor response element binding proteins NF90 and NF45. J. Biol. Chem. 273, 2136-2145.
25. Langland JO, Kao PN, Jacobs BL (1999) Nuclear factor-90 of activated T-cells: a double-stranded RNA-binding protein and substrate for the double-stranded RNA-dependent protein kinase, PKR. Biochemistry 38, 6361-6368.
26. Parker LM, Fierro-Monti I, Mathews MB (2001) Nuclear factor 90 is a substrate and regulator of the eukaryotic initiation factor 2 kinase double-stranded RNA-activated protein kinase. J. Biol. Chem. 276, 32522-32530.
27. Nie Y, Ding L, Kao PN, Braun R, Yang JH (2005) ADAR1 interacts with NF90 through double-stranded RNA and regulates NF90-mediated gene expression independently of RNA editing. Mol. Cell. Biol. 25, 6956-6963.
28. Xu YH, Grabowski GA (2005) Translation modulation of acid beta-glucosidase in HepG2 cells: participation of the PKC pathway. Mol. Genet. Metab. 84, 252-264.
29. Pei Y, Zhu P, Dang Y, Wu J, Yang X, Wan B et al. (2008) Nuclear export of NF90 to stabilize IL-2 mRNA is mediated by AKT-dependent phosphorylation at Ser647 in response to CD28 costimulation. J. Immunol. 180, 222-229.
30. Beausoleil SA, Jedrychowski M, Schwartz D, Elias JE, Villen J, Li J et al. (2004) Large-scale characterization of HeLa cell nuclear phosphoproteins. Proc. Natl. Acad. Sci. USA 101, 12130-12135.
31. Chen RQ, Yang QK, Lu BW, Yi W, Cantin G, Chen YL et al. (2009) CDC25B mediates rapamycin-induced oncogenic responses in cancer cells. Cancer Res. 69, 2663-2668.
32. Dephoure N, Zhou C, Villen J, Beausoleil SA, Bakalarski CE, Elledge SJ et al. (2008) A quantitative atlas of mitotic phosphorylation. Proc. Natl. Acad. Sci. USA 105, 10762-10767.
33. Van Hoof D, Munoz J, Braam SR, Pinkse MW, Linding R, Heck AJ et al. (2009) Phosphorylation dynamics during early differentiation of human embryonic stem cells. Cell Stem Cell 5, 214-226.
34. Westendorf JM, Rao PN, Gerace L (1994) Cloning of cDNAs for M-phase phosphoproteins recognized by the MPM2 monoclonal antibody and determination of the phosphorylated epitope. Proc. Natl. Acad. Sci. USA 91, 714-718.
35. Darbon JM, Valette A, Bayard F (1986) Phorbol esters inhibit the proliferation of MCF-7 cells. Possible implication of protein kinase C. Biochem. Pharmacol. 35, 2683-2686.
36. Osborne CK, Hamilton B, Nover M, Ziegler J (1981) Antagonism between epidermal growth factor and phorbol ester tumor promoters in human breast cancer cells. J. Clin. Invest. 67, 943-951.
37. Valette A, Gas N, Jozan S, Roubinet F, Dupont MA, Bayard F (1987) Influence of 12-O-tetradecanoylphorbol-13-acetate on proliferation and maturation of human breast carcinoma cells (MCF-7): relationship to cell cycle events. Cancer Res. 47, 1615-1620.
38. de Vente JE, Kukoly CA, Bryant WO, Posekany KJ, Chen J, Fletcher DJ et al. (1995) Phorbol esters induce death in MCF-7 breast cancer cells with altered expression of protein kinase C isoforms. Role for p53-independent induction of gadd-45 in initiating death. J. Clin. Invest. 96, 1874-1886.
39. Narvaez CJ, Welsh J (1997) Differential effects of 1, 25-dihydroxyvitamin D3 and tetradecanoylphorbol acetate on cell cycle and apoptosis of MCF-7 cells and a vitamin D3-resistant variant. Endocrinology 138, 4690-4698.
40. Nakajima H, Toyoshima-Morimoto F, Taniguchi E, Nishida E (2003) Identification of a consensus motif for Plk (Polo-like kinase) phosphorylation reveals Myt1 as a Plk1 substrate. J. Biol. Chem. 278, 25277-25280.
41. Ahonen LJ, Kallio MJ, Daum JR, Bolton M, Manke IA, Yaffe MB et al. (2005) Polo-like kinase 1 creates the tension-sensing 3F3/2 phosphoepitope and modulates the association of spindle-checkpoint proteins at kinetochores. Curr. Biol. 15, 1078-1089.
42. Barr FA, Sillje HH, Nigg EA (2004) Polo-like kinases and the orchestration of cell division. Nat. Rev. Mol. Cell Biol. 5, 429-440.
43. van de Weerdt BC, Littler DR, Klompmaker R, Huseinovic A, Fish A, Perrakis A et al. (2008) Polo-box domains confer target specificity to the Polo-like kinase family. Biochim. Biophys. Acta 1783, 1015-1022.
44. Elia AE, Cantley LC, Yaffe MB (2003) Proteomic screen finds pSer/pThr-binding domain localizing Plk1 to mitotic substrates. Science 299, 1228-1231.